Literature DB >> 33629312

Impact of miR-155 (rs767649 A>T) and miR-146a (rs57095329 A>G) polymorphisms in System Lupus Erythematosus susceptibility in an Egyptian cohort.

S R Mohammed1, O G Shaker, A A Mohammed, N A Fouad, H A Hussein, N A Ahmed, O M Ahmed, D Y Ali, M M Mohamed, A A Ibrahim.   

Abstract

OBJECTIVE: Systemic Lupus Erythematosus (SLE) is an autoimmune inflammatory disease. miR-155 and miR-146a were expressed in many autoimmune diseases such as rheumatoid arthritis. The aim of this study was to examine miR-155 rs767649 and miR-146a rs57095329 polymorphisms in SLE susceptibility in an Egyptian cohort and to investigate the correlation between them and clinical data and disease activity. PATIENTS AND METHODS: The two SNPs were analyzed in 120 patients with SLE and 100 healthy controls using RT-PCR.
RESULTS: The TT genotype and T allele of miR-155 rs767649 were associated with a significant increase in the risk of SLE, particularly in females. On the other hand, miR-146a (rs57095329) polymorphism was not associated with SLE risk. The AT/TT genotypes of miR-155 rs767649 showed higher distributions among patients with higher SLEDAI and nephritis.
CONCLUSIONS: This study had demonstrated for the first time the association between miR-155 rs767649 and the risk of development of SLE in an Egyptian cohort, mostly in females.

Entities:  

Year:  2021        PMID: 33629312     DOI: 10.26355/eurrev_202102_24850

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  2 in total

1.  mir-146a genetic polymorphisms in systemic lupus erythematosus patients: Correlation with disease manifestations.

Authors:  Basima A El-Akhras; Yasser B M Ali; Samir A El-Masry; Iman H Bassyouni; Ibrahim H El-Sayed; Roba M Talaat
Journal:  Noncoding RNA Res       Date:  2022-05-26

Review 2.  Association of Immune-Related Genetic and Epigenetic Alterations with Lupus Nephritis.

Authors:  Xiaole Mei; Hui Jin; Ming Zhao; Qianjin Lu
Journal:  Kidney Dis (Basel)       Date:  2022-06-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.